These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 27519954

  • 1. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q, Gong FQ, Shang SQ, Hu J.
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [Abstract] [Full Text] [Related]

  • 2. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H, Hasegawa S, Suzuki Y, Kudo K, Ichiyama T.
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [Abstract] [Full Text] [Related]

  • 3. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
    Matsuguma C, Wakiguchi H, Suzuki Y, Okada S, Furuta T, Ohnishi Y, Azuma Y, Ohga S, Hasegawa S.
    Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
    [Abstract] [Full Text] [Related]

  • 4. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
    Zhang YY, Huang XM, Kang ML, Gong FQ, Qian BQ.
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706
    [Abstract] [Full Text] [Related]

  • 5. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Hirabayashi Y, Takahashi Y, Xu Y, Akane K, Villalobos IB, Okuno Y, Hasegawa S, Muramatsu H, Hama A, Kato T, Kojima S.
    Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
    [Abstract] [Full Text] [Related]

  • 6. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS, Cowan KR, Walsh AM, Hamilton WS, Goldman FD.
    Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
    [Abstract] [Full Text] [Related]

  • 7. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
    Cho HJ, Bak SY, Kim SY, Yoo R, Baek HS, Yang S, Hwang IT, Ban JE.
    Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
    [Abstract] [Full Text] [Related]

  • 8. Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia.
    Chen Y, Zhou Y, Chen P, Zhang P, Jia M, Tang Y.
    Thromb Res; 2019 Aug; 180():1-9. PubMed ID: 31146120
    [Abstract] [Full Text] [Related]

  • 9. The effect of intravenous immunoglobulin on lymphocyte populations in children with Kawasaki syndrome.
    Saulsbury FT.
    Clin Exp Rheumatol; 1992 Aug; 10(6):617-20. PubMed ID: 1483316
    [Abstract] [Full Text] [Related]

  • 10. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
    Pietra BA, De Inocencio J, Giannini EH, Hirsch R.
    J Immunol; 1994 Aug 15; 153(4):1881-8. PubMed ID: 7913945
    [Abstract] [Full Text] [Related]

  • 11. Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4+ T Cells in Children With Acute Kawasaki Disease.
    Wang N, Chen Z, Zhang F, Zhang Q, Sun L, Lv H, Wang B, Shen J, Zhou X, Chen F, Zhang B, Meng L, Zhou H, Bai Z, Huang J.
    Front Immunol; 2022 Aug 15; 13():802690. PubMed ID: 35222381
    [Abstract] [Full Text] [Related]

  • 12. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
    Burns JC, Song Y, Bujold M, Shimizu C, Kanegaye JT, Tremoulet AH, Franco A.
    Clin Exp Immunol; 2013 Dec 15; 174(3):337-44. PubMed ID: 23901839
    [Abstract] [Full Text] [Related]

  • 13. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
    Ehara H, Kiyohara K, Izumisawa Y, Ito T.
    Cell Immunol; 2010 Dec 15; 265(1):57-64. PubMed ID: 20673885
    [Abstract] [Full Text] [Related]

  • 14. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A, Rogala E, Bednarek W, Barczyński B, Wertel I, Piekarczyk W, Kotarski J.
    Ginekol Pol; 2012 Oct 15; 83(10):737-43. PubMed ID: 23383558
    [Abstract] [Full Text] [Related]

  • 15. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease.
    Lee HK, Kim DS, Noh GW, Lee KY.
    Yonsei Med J; 1996 Oct 15; 37(5):357-63. PubMed ID: 8997168
    [Abstract] [Full Text] [Related]

  • 16. Activin a suppresses peripheral CD8+ T lymphocyte activity in acute-phase Kawasaki disease.
    Wu Q, Weng R, Xu Y, Wang L, Huang Y, Yang J.
    BMC Immunol; 2021 Feb 23; 22(1):17. PubMed ID: 33622252
    [Abstract] [Full Text] [Related]

  • 17. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
    Burns JC, Touma R, Song Y, Padilla RL, Tremoulet AH, Sidney J, Sette A, Franco A.
    Autoimmunity; 2015 May 23; 48(3):181-8. PubMed ID: 25822882
    [Abstract] [Full Text] [Related]

  • 18. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
    Am J Ther; 2016 May 23; 23(6):e1293-e1299. PubMed ID: 25611359
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 23; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 20. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K, Głowacka E, Kulig A, Lewy-Trenda I, Bryś M, Lewkowicz P.
    Folia Histochem Cytobiol; 2011 Apr 23; 49(4):579-92. PubMed ID: 22252752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.